Xiaoya Cai
1095 Jie Fang Avenue
Wuhan, 430030, China
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction to: Significance of targeting DNMT3A mutations in AML.
Journal: Annals of hematology
Published: March 13, 2026
Global welfare burden of hematologic malignancies from 2015 to 2023.
Journal: iScience
Published: December 07, 2025
INSR/AKT1 axis promotes cells proliferation and migration in acute myeloid leukemia.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: September 03, 2025
Clinical outcomes with high dose cytarabine and idarubicin consolidation for adult AML patients.
Journal: Annals of hematology
Published: March 05, 2025
Short-Course Blinatumomab Treatment as a Bridge to Further Salvage Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: A Retrospective Single-Center Study.
Journal: Cancer medicine
Published: November 01, 2024
Global, regional, and national burden of acute myeloid leukemia, 1990-2021: a systematic analysis for the global burden of disease study 2021.
Journal: Biomarker research
Published: August 24, 2024
Significance of targeting DNMT3A mutations in AML.
Journal: Annals of hematology
Published: April 18, 2024
XPO1 inhibition displays anti-leukemia efficacy against DNMT3A-mutant acute myeloid leukemia via downregulating glutathione pathway.
Journal: Annals of hematology
Published: January 18, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026